Topoisomerase-based reagents and methods for molecular cloning
View Patent ↗This invention provides a modified vaccinia topoisomerase enzyme containing an affinity tag which is capable of facilitating purification of protein-DNA complexes away from unbound DNA. This invention further provides a modified sequence specific topoisomerase enzyme. This invention provides a method of ligating duplex DNAs, a method of molecular cloning of DNA, a method of synthesizing polynucleotides, and a method of gene targeting. Lastly, this invention provides a recombinant DNA molecule composed of segments of DNA which have been joined ex vivo by the use of a sequence specific topoisomerase and which has the capacity to transform a suitable host cell comprising a DNA sequence encoding polypeptide activity.
1. A method for ligating duplex DNAs comprising contacting a first duplex DNA with a second duplex DNA, wherein (a) the first duplex DNA has a site-specific type I topoisomerase covalently bound at each of its ends; (b) the second duplex DNA has a terminal hydroxyl at each end; and (c) the contacting is done under conditions permitting the site-specific type I topoisomerase to ligate the first duplex DNA to the second duplex DNA, thereby ligating the first and second duplex DNAs.
2. The method of claim 1 , wherein the type I topoisomerase is a vaccinia topoisomerase.
3. The method of claim 2 , wherein the vaccinia topoisomerase comprises an affinity tag.
4. The method of claim 3 , wherein the affinity tag is histidine, polyhistidine, glutathione-S-transferase or maltose binding protein.
5. The method of claim 1 , wherein the first or second duplex DNA further comprises an affinity tag.
6. The method of claim 5 , wherein the affinity tag is biotin.
7. The method of claim 1 , wherein the first or second duplex DNA is a plasmid vector.
8. The method of claim 1 , wherein at least one end of the first duplex DNA comprises an overhang that is complementary to an overhang of the second duplex DNA.
9. The method of claim 8 , wherein the overhang is 2–12 nucleotides long.
10. The method of claim 9 , wherein the overhang is two nucleotide bases long.
11. The method of claim 9 , wherein the overhang comprises a restriction endonuclease half-site.
12. A method for ligating duplex DNAs comprising contacting a first duplex DNA with a second duplex DNA, wherein (a) the first duplex DNA has a site-specific type I topoisomerase covalently bound at one end; (b) the second duplex DNA has a terminal hydroxyl end; (c)(i) the site-specific type I topoisomerase and/or (ii) the first and/or second duplex DNA further comprises an affinity tag; and (d) the contacting is done under conditions permitting the site-specific type I topoisomerase to ligate the first duplex DNA to the second duplex DNA, thereby ligating the first and second duplex DNAs.
13. The method of claim 12 , wherein the type I topoisomerase is a vaccinia topoisomerase.
14. The method of claim 13 , wherein the vaccinia topoisomerase comprises an affinity tag.
15. The method of claim 14 , wherein the affinity tag is histidine, polyhistidine, glutathione-S-transferase or maltose binding protein.
16. The method of claim 12 , wherein the first or second duplex DNA further comprises an affinity tag.
17. The method of claim 16 , wherein the affinity tag is biotin.
18. The method of claim 12 , wherein the first or second duplex DNA is a plasmid vector.
19. The method of claim 12 , wherein the topoisomerase-bound end of the first duplex DNA comprises an overhang that is complementary to an overhang at the hydroxyl-terminated end of the second duplex DNA.
20. The method of claim 19 , wherein the overhang is 2–12 nucleotide bases long.
21. The method of claim 20 , wherein the overhang is two nucleotide bases long.
22. The method of claim 20 , wherein the overhang comprises a restriction endonuclease half-site.
23. The method of claim 12 , wherein the method is repeated a plurality of times so as to concatenate three or more duplex DNAs.